Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Dihydroberberine has anti-atherosclerotic, anti-inflammatory, hypolipidemic and antitumor activities. It inhibits human ether-a-go-go-related gene (hERG) channels and remarkably reduces Hsp90 expression and its interaction with hERG.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 9,500 | |||
5 mg | 在庫あり | ¥ 22,500 | |||
10 mg | 在庫あり | ¥ 39,500 | |||
25 mg | 在庫あり | ¥ 74,000 | |||
50 mg | 在庫あり | ¥ 110,000 | |||
100 mg | 在庫あり | ¥ 158,000 |
分子量 | 337.37 |
分子式 | C20H19NO4 |
CAS No. | 483-15-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 3.37 mg/mL (10 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Dihydroberberine 483-15-8 Angiogenesis Cytoskeletal Signaling JAK/STAT signaling Membrane transporter/Ion channel Metabolism Tyrosine Kinase/Adaptors HSP Potassium Channel HER inhibit KcsA Inhibitor Heat shock proteins inhibitor